These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7937148)

  • 1. Selective synergy of immunoglobulin enhancer elements in B-cell development: a characteristic of kappa light chain enhancers, but not heavy chain enhancers.
    Fulton R; van Ness B
    Nucleic Acids Res; 1994 Oct; 22(20):4216-23. PubMed ID: 7937148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa immunoglobulin promoters and enhancers display developmentally controlled interactions.
    Fulton R; Van Ness B
    Nucleic Acids Res; 1993 Oct; 21(21):4941-7. PubMed ID: 8177743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of E mu, 3'alpha (hs 1,2) and 3'kappa enhancers on mutation of an Ig-VDJ-Cgamma2a Ig heavy gene in cultured B cells.
    Lin MM; Green NS; Zhang W; Scharff MD
    Int Immunol; 1998 Aug; 10(8):1121-9. PubMed ID: 9723698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A factor known to bind to endogenous Ig heavy chain enhancer only in lymphocytes is a ubiquitously active transcription factor.
    Elmaleh N; Matthias P; Schaffner W
    Eur J Biochem; 1990 Feb; 187(3):507-13. PubMed ID: 2105887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunoglobulin kappa locus contains a second, stronger B-cell-specific enhancer which is located downstream of the constant region.
    Meyer KB; Neuberger MS
    EMBO J; 1989 Jul; 8(7):1959-64. PubMed ID: 2507312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility.
    Lenardo M; Pierce JW; Baltimore D
    Science; 1987 Jun; 236(4808):1573-7. PubMed ID: 3109035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.
    Park K; Atchison ML
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9804-8. PubMed ID: 1946405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic hypermutation of a lambda 2 transgene under the control of the lambda enhancer or the heavy chain intron enhancer.
    Klotz EL; Storb U
    J Immunol; 1996 Nov; 157(10):4458-63. PubMed ID: 8906822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergism between immunoglobulin enhancers and promoters.
    Garcia JV; Bich-Thuy LT; Stafford J; Queen C
    Nature; 1986 Jul 24-30; 322(6077):383-5. PubMed ID: 3016550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential interactions between the immunoglobulin heavy chain mu intron and 3' enhancer.
    Mocikat R; Kardinal C; Klobeck HG
    Eur J Immunol; 1995 Nov; 25(11):3195-8. PubMed ID: 7489764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif.
    Henthorn P; Kiledjian M; Kadesch T
    Science; 1990 Jan; 247(4941):467-70. PubMed ID: 2105528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin heavy chain enhancer is located near or in an initiation zone of chromosomal DNA replication.
    Ariizumi K; Wang Z; Tucker PW
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3695-9. PubMed ID: 8475117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinant differences between the rabbit and mouse immunoglobulin kappa enhancers impair the activity of the rabbit enhancer in mouse myeloma cells.
    Akimenko MA; Ekker M; Doyen N; Biben C; Rougeon F
    Nucleic Acids Res; 1989 Jun; 17(12):4745-55. PubMed ID: 2501761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the rat immunoglobulin heavy-chain 3' enhancer is position dependent.
    Mocikat R; Harloff C; Kütemeier G
    Gene; 1993 Dec; 136(1-2):349-53. PubMed ID: 8294030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU.
    Wittekindt NE; Hörtnagel K; Geltinger C; Polack A
    Nucleic Acids Res; 2000 Feb; 28(3):800-8. PubMed ID: 10637333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of the 3'-enhancer region in immunoglobulin kappa gene expression.
    Meyer KB; Sharpe MJ; Surani MA; Neuberger MS
    Nucleic Acids Res; 1990 Oct; 18(19):5609-15. PubMed ID: 2120679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line.
    Schlissel M; Voronova A; Baltimore D
    Genes Dev; 1991 Aug; 5(8):1367-76. PubMed ID: 1714414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple nuclear factors interact with the immunoglobulin enhancer sequences.
    Sen R; Baltimore D
    Cell; 1986 Aug; 46(5):705-16. PubMed ID: 3091258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental regulation of the kappa locus involves both positive and negative sequence elements in the 3' enhancer that affect synergy with the intron enhancer.
    Liu X; Prabhu A; Van Ness B
    J Biol Chem; 1999 Feb; 274(6):3285-93. PubMed ID: 9920868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the role of the 3'alpha heavy chain enhancer [3'alpha E(hs1,2)] in Vh gene somatic hypermutation.
    Tumas-Brundage KM; Vora KA; Manser T
    Mol Immunol; 1997 Apr; 34(5):367-78. PubMed ID: 9293770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.